These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30965331)

  • 1. Fetuin-B Links Nonalcoholic Fatty Liver Disease to Chronic Kidney Disease in Obese Chinese Adults: A Cross-Sectional Study.
    Lin M; Liu C; Liu Y; Wang D; Zheng C; Shi X; Chen Z; Liu J; Li X; Yang S; Li Z
    Ann Nutr Metab; 2019; 74(4):287-295. PubMed ID: 30965331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.
    Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X
    Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Fetuin-B with Subclinical Atherosclerosis in Obese Chinese Adults.
    Li Z; He C; Liu Y; Wang D; Lin M; Liu C; Shi X; Chen Z; Li X; Yang S; Li W
    J Atheroscler Thromb; 2020 May; 27(5):418-428. PubMed ID: 31527322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes.
    El-Ashmawy HM; Ahmed AM
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):859-864. PubMed ID: 30601337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum fetuin-B is positively associated with intrahepatic triglyceride content and increases the risk of insulin resistance in obese Chinese adults: A cross-sectional study.
    Wang D; Liu Y; Liu S; Lin L; Liu C; Shi X; Chen Z; Lin M; Yang S; Li Z; Li X
    J Diabetes; 2018 Jul; 10(7):581-588. PubMed ID: 29194974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study.
    Zhu J; Wan X; Wang Y; Zhu K; Li C; Yu C; Li Y
    Endocrine; 2017 Apr; 56(1):208-211. PubMed ID: 27628583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease.
    Tanaka M; Mori K; Takahashi S; Higashiura Y; Ohnishi H; Hanawa N; Furuhashi M
    Nephrol Dial Transplant; 2023 Feb; 38(3):700-711. PubMed ID: 35612975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease.
    Pampanini V; Inzaghi E; Germani D; Alterio A; Puglianiello A; Alisi A; Nobili V; Cianfarani S
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):71-76. PubMed ID: 29122442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
    Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994.
    Sirota JC; McFann K; Targher G; Chonchol M; Jalal DI
    Am J Nephrol; 2012; 36(5):466-71. PubMed ID: 23128368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease.
    Ebert T; Linder N; Schaudinn A; Busse H; Berger J; Lichtinghagen R; Keim V; Wiegand J; Karlas T
    Endocrine; 2017 Nov; 58(2):246-252. PubMed ID: 28914407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic triglyceride content is independently associated with chronic kidney disease in obese adults: A cross-sectional study.
    Pan LL; Zhang HJ; Huang ZF; Sun Q; Chen Z; Li ZB; Yang SY; Li XY; Li XJ
    Metabolism; 2015 Sep; 64(9):1077-85. PubMed ID: 26144271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of non-alcoholic fatty liver disease and serum uric acid with subclinical atherosclerosis in obese Chinese adults.
    Liu Y; Liu C; Shi X; Lin M; Yan B; Zeng X; Chen N; Lu S; Liu S; Yang S; Li X; Li Z
    J Diabetes; 2017 Jun; 9(6):586-595. PubMed ID: 27371101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease.
    Choe AR; Ryu DR; Kim HY; Lee HA; Lim J; Kim JS; Lee JK; Kim TH; Yoo K
    BMC Nephrol; 2020 Feb; 21(1):50. PubMed ID: 32066395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAFLD and risk of CKD.
    Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
    Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
    Rametta R; Ruscica M; Dongiovanni P; Macchi C; Fracanzani AL; Steffani L; Fargion S; Magni P; Valenti L
    Eur J Clin Invest; 2014 Jul; 44(7):627-33. PubMed ID: 24828988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum irisin and body composition with chronic kidney disease in obese Chinese adults: a cross-sectional study.
    Yang S; Xiao F; Pan L; Zhang H; Ma Z; Liu S; Liu Y; Zhang W; Zeng X; Liu C; Li X; Li X; Li Z
    BMC Nephrol; 2015 Feb; 16():16. PubMed ID: 25884312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease: A Strobe-Compliant Article.
    Huang Y; Huang X; Ding L; Wang P; Peng K; Chen Y; Dai M; Zhang D; Xu M; Bi Y; Wang W
    Medicine (Baltimore); 2015 Sep; 94(39):e1517. PubMed ID: 26426614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults.
    Liu CQ; He CM; Chen N; Wang D; Shi X; Liu Y; Zeng X; Yan B; Liu S; Yang S; Li X; Li X; Li Z
    Sci Rep; 2016 Dec; 6():38605. PubMed ID: 27924915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic steatohepatitis and increased risk of chronic kidney disease.
    Yasui K; Sumida Y; Mori Y; Mitsuyoshi H; Minami M; Itoh Y; Kanemasa K; Matsubara H; Okanoue T; Yoshikawa T
    Metabolism; 2011 May; 60(5):735-9. PubMed ID: 20817213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.